About ECCO
ECCO General Assembly
ECCO Governing Board
The Council of National Representatives
Solidarity for Ukraine
ECCO Operational Board / Committees
Committee Podcasts
Affiliate ECCO Societies & ECCO Partners
ECCO Office
ECCO Disclosures
ECCO Elections
Congresses & Events
Future
19th Congress of ECCO 2024 - Stockholm
Past
18th Congress of ECCO 2023 - Copenhagen
Event Calendar
Quality Assurance/Endorsement
Congress Statistics
Membership
Individual Membership
Country Members
Corporate Membership
Affiliate ECCO Societies
Education
E-QUALITY
e-CCO Learning
Educational Workshops
Congress Educational Programme
IBD Nurse Education Programme
Y-ECCO Mentorship Forum
Letters from the e-Learning Ambassador
Science
UR-CARE
The Reviewers of ECCO
The Reviewers of 2022
Fellowships and Grants
ECCO Young Researcher Award
Scientific Workshops
Research Projects
BIOCYCLE Dissemination Workshops
ECCO CONFER Cases
Job postings
Publications
JCC
ECCO Guidelines
ECCO Topical Review
ECCO Position Statements
ECCO Scientific Workshop Papers
ECCO News
ECCO IBD App
ECCO Congress Abstracts
Surveys
Other publications
COVID-19
20years Anniversary Book
eNewsletter
Search
Author
Title
Category
Choose
Abstracts 2023
Abstracts 2022
Abstract 2021
Search
Clear
Poster presentations: Epidemiology 2022
P628 Processed and ultra-processed food and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)
P629 Evolution of disease phenotype, time to biological therapy and medium-, long-term surgery rates in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort
P630 Systematic review and meta-analysis: Diagnostic delay and the subsequent impact on the disease course of adult Inflammatory Bowel Disease
P631 Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases. -A nationwide, retrospective study-
P632 Estimating indirect and out-of-pocket disease-associated costs in paediatric Inflammatory Bowel Disease: a nation-wide cross-sectional analysis
P635 Incidence, prevalence, disease phenotype and maximal therapeutic step in Ulcerative Colitis patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem County cohort
P636 Work disability after 20 years with Inflammatory Bowel Disease - results from the IBSEN study
P637 Risks of Development of COVID-19 among Patients with Inflammatory Bowel Disease
P639 Incidence and disease presentation of inflammatory bowel disease in Denmark: initial findings from a Copenhagen IBD Inception Cohort Study
P640 Incidence, prevalence, disease phenotype and maximal therapeutic step in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort
P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey
P642 Crossroads of vitamin B6 deficiency and inflammation in inflammatory bowel disease: Preliminary results of a cross-sectional study
P643 Generalizability of Crohn’s disease randomized controlled trials compared to clinical practice
P644 Impact of Postoperative Treatment with Immunomodulators and Anti-TNFα agents on long-term Reoperation Rate in ileocaecal Crohn’s Disease.
P645 Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD Registry
P646 Will the screening of SARS-COV-2 infection in IBD infusion centers be useful?
P647 Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series
P648 Prevalence and Impact of Alcohol Consumption and Cannabis Use on Inflammatory Bowel Diseases
P649 The impact of COVID-19 on quality of life among patients with inflammatory bowel diseases – A Danish prospective population-based cohort study
P650 IBD care from the patient perspective: The patient's turn
P652 The burden of mental illness, including deliberate self-harm, before and after a diagnosis of IBD, a UK population study.
P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark
P654 Clinical outcomes in familial versus sporadic inflammatory bowel disease diagnosed in the era of biological therapies. Prospective data from the ENEIDA registry.
P655 Early life mebendazole exposure increases the risk of adult-onset ulcerative colitis: a population-based cohort study
P656 The impact of periodontitis on IBD disease activity
P657 Persistence in smoking cessation in inflammatory bowel disease (IBD)
P658 Evolution of disease phenotype, time to biological therapy and medium-, long-term colectomy rates in Ulcerative Colitis patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort
P659 No decrease in number of new Inflammatory Bowel Disease diagnoses in children in the Netherlands during the Covid-19 pandemic: a nationwide retrospective cohort study
P660 Knowledge, attitudes, and awareness of contraceptive choices in women with Inflammatory Bowel Disease
P661 Pre-diagnostic vitamin D levels in Inflammatory Bowel Disease
P662 Colorectal Cancer in Patients with Ulcerative Colitis: A National Cohort Study between 1991-2020
P663 Mild COVID-19 disease and breakthrough cases among children with inflammatory bowel disease: An update from an international registry
P664 Bidirectional association between inflammatory bowel disease and psoriasis in a pediatric population: A nationwide insurance claim data analysis in South Korea.
P665 Towards FAIR longitudinal IBD registries: preliminary results of an iterative design process of a reusable and interoperable IBD database model
P666 Trend of Lower gastrointestinal Endoscopy in Patients with Inflammatory Bowel Diseases : A Nationwide Population-Based Study in South Korea
P667 Unmet needs in the management of Inflammatory Bowel Diseases in Egypt
P668 Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease
P669 Validation of prior infliximab exposure and total colectomy outcome in patients with ulcerative colitis in Sweden
P670 Familial Inflammatory Bowel Disease is associated with a more adverse disease compared to sporadic cases
P671 Occurrence and clinical impact of eosinophilic esophagitis in a large cohort of children with Inflammatory Bowel Disease.
P672 Biologic therapy for Inflammatory Bowel Disease in Poland in 2020: nationwide data.
P673 Trends in inflammatory bowel disease infections and vaccinations in the past four decades - a high-level text mining analysis of PubMed publications.
P674 Predictors of response to biologics in Crohn's Diseases: A population-based study from the epi-IIRN
P675 Associations between Inflammatory Bowel Disease, social isolation, and mortality: evidence from UK Biobank cohort study
P676 Burden of depression and anxiety among inflammatory bowel disease patients in a national cohort in Israel – Data from the EPI-IIRN
P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry
P678 Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry
P679 Inflammatory Bowel Disease and cancer risk in the IBSEN study after 30 years of follow-up.
P680 Epidemiology of Inflammatory Bowel Disease in Poland 2009-2020: nationwide data
P681 Impact of Crohn’s disease on survival in Korean patients with small bowel adenocarcinoma
P682 Predictors of response to biologics in Ulcerative Colitis: A population-based study from the epi-IIRN
P683 Discontinuation of infliximab treatment: a comparison between IBD patients who retransitioned to originator and those who remained on biosimilar
P684 Increased risk of cardiovascular disease and high risk profiles compatible with metabolic syndrome in patients with Inflammatory Bowel Disease: a cross-sectional analysis of matched cohorts
P685 Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases
P686 Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study
P687 Prevalence of iron deficiency and anaemia in the outpatient Inflammatory Bowel Disease population: a Dutch national cross-sectional study
P688 Sex difference in inflammatory bowel disease patients regarding depression: a nationwide population based study in Korea
P689 Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan
P690 Rates of IBD in New Zealand Māori population at Lakes District Health Board: low but increasing
P691 Influence of ethnicity on the phenotype and clinical outcomes in Inflammatory Bowel Disease; comparison of a South American with a North American population.
P692 Clinical, therapeutic and evolutionary profile of fistulizing ano-perineal lesions in Crohn's disease
P693 Willingness and hesitancy to the telemedicine in patients with inflammatory bowel disease during COVID-19 outbreak. Preliminary results of a survey in an Italian IBD Center
P694 COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy.
P695 Attitudes and predictors of COVID-19 vaccine uptake in patients with Inflammatory Bowel Disease
About ECCO
ECCO General Assembly
ECCO Governing Board
The Council of National Representatives
Solidarity for Ukraine
ECCO Operational Board / Committees
Committee Podcasts
Affiliate ECCO Societies & ECCO Partners
ECCO Office
ECCO Disclosures
ECCO Elections
Congresses & Events
Future
19th Congress of ECCO 2024 - Stockholm
Past
18th Congress of ECCO 2023 - Copenhagen
Event Calendar
Quality Assurance/Endorsement
Congress Statistics
Membership
Individual Membership
Country Members
Corporate Membership
Affiliate ECCO Societies
Education
E-QUALITY
e-CCO Learning
Educational Workshops
Congress Educational Programme
IBD Nurse Education Programme
Y-ECCO Mentorship Forum
Letters from the e-Learning Ambassador
Science
UR-CARE
The Reviewers of ECCO
The Reviewers of 2022
Fellowships and Grants
ECCO Young Researcher Award
Scientific Workshops
Research Projects
BIOCYCLE Dissemination Workshops
ECCO CONFER Cases
Job postings
Publications
JCC
ECCO Guidelines
ECCO Topical Review
ECCO Position Statements
ECCO Scientific Workshop Papers
ECCO News
ECCO IBD App
ECCO Congress Abstracts
Surveys
Other publications
COVID-19
20years Anniversary Book
eNewsletter